← Eichor
Study identifier: NCT07100574 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Bacteria in Dental Plaque and Atheroma Plaque

Condition: Gingival Inflammation · Dental Plaque · Atheroma Plaque  ·  Sponsor: Istanbul Saglik Bilimleri University

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Periodontitis is considered a focus of infection where oral bacteria, bacterial by-products or inflammatory mediators can interact with other parts of the organism via the blood. Periodontal pathogen components such as DNA, RNA or specific antigens of P. gingivalis, Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Treponema denticola (T. denticola), Fusobacterium nucleatum (F. nucleatum) or Campylobacter rectus have been isolated from different tissues such as atheroma plaques, placenta, amniotic sac and respiratory tract. It has been reported that periodontitis may contribute to endothelial dysfunction leading to the formation of atherosclerosis.

This description comes directly from the study's public registry record.

Talk to the study team

Ayşe Toraman  ·  05385025422  ·  draysetoraman@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Health Sciences University, Hamidiye Faculty of Dentistry, Department of PeriodontologyIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07100574